1939
DOI: 10.1136/sti.15.2.83
|View full text |Cite
|
Sign up to set email alerts
|

The Chemotherapy of Sulphon-Amides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…They reversibly inhibit the synthesis of folic acid through binding to dihydropteroate synthase (DHPS), a catalytic enzyme in the folic acid biosynthesis pathway. Sulfonamide resistance was first reported around 1938, where particular strains of Streptococcus did not respond to the bactericidal effects of sulfonamide (Buttle, 1939). Vertically acquired resistance to sulfonamides is conferred by mutations in the chromosomal DHPS gene (folP), enabling bacteria to produce altered forms of the DHPS enzyme that are resistant to inhibition by the drug (Skold, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…They reversibly inhibit the synthesis of folic acid through binding to dihydropteroate synthase (DHPS), a catalytic enzyme in the folic acid biosynthesis pathway. Sulfonamide resistance was first reported around 1938, where particular strains of Streptococcus did not respond to the bactericidal effects of sulfonamide (Buttle, 1939). Vertically acquired resistance to sulfonamides is conferred by mutations in the chromosomal DHPS gene (folP), enabling bacteria to produce altered forms of the DHPS enzyme that are resistant to inhibition by the drug (Skold, 2000).…”
Section: Introductionmentioning
confidence: 99%